logo
CDC adjusts COVID vaccine guidance, but keeps on child schedule

CDC adjusts COVID vaccine guidance, but keeps on child schedule

Yahoo2 days ago

The Centers for Disease Control and Prevention has issued updated advice on the COVID-19 vaccine days after Health and Human Services Secretary Robert F. Kennedy Jr said the agency would no longer recommend the shot to children and pregnant women.
The agency has kept the shot on its vaccine schedule for children between the ages of 6 months to 17 years of age, despite Kennedy saying they would no longer be recommended.
The CDC says children with no underlying health condition 'may receive' COVID-19 vaccines, instead of broadly recommending that all children should get the inoculation. It now advises 'shared clinical decision-making' between parents and physicians.
'Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive COVID-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances,' the guidelines now say.
The changes to the CDC's recommendations for children mean that health insurance companies are still ostensibly required to cover the shot, at least for now.
However, there is a history of some health insurance companies not covering drugs listed on 'shared clinical decision-making' recommendations, healthcare lawyer Richard Hughes IV said in an email.
'Based on my collective observations of payer coverage of vaccines, the bottom line is expect variability in coverage, prior authorization and out-of-pocket, all of which will discourage uptake.'
Kennedy said Tuesday the CDC would no longer recommend routine COVID-19 shots for healthy children and pregnant women in a post on the social media platform X.
'Last year, the Biden administration urged healthy children to get yet another COVID shot, despite the lack of any clinical data to support the repeat booster strategy in children,' Kennedy said in a video, joined by Food and Drug Administration (FDA) Commissioner Marty Makary and National Institutes of Health (NIH) Director Jay Bhattacharya.
'It's common sense, and it's good science,' Bhattacharya said of the change.
It's unclear how COVID-19 vaccine guidelines will change for pregnant women. The CDC's stance on COVID-19 vaccines during pregnancy is now 'no guidance,' per a memo released from the agency Friday, according to The New York Times. The vaccine was previously recommended for all pregnant people.
The CDC's website also continues to host pages of guidance recommending that pregnant women continue to receive the COVID-19 vaccine because of the higher risk they have of developing serious illness from the disease.
'Studies including hundreds of thousands of people around the world show that COVID-19 vaccination before and during pregnancy is safe, effective, and beneficial to both the pregnant woman and the baby,' the website states.
The Department of Health and Human Services has yet to respond to questions about the new guidelines from The Hill.
Nathaniel Weixel contributed.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Business Insider

time2 hours ago

  • Business Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:

Scott Bessent dismisses Jamie Dimon's debt concerns, saying none of his past predictions have been right
Scott Bessent dismisses Jamie Dimon's debt concerns, saying none of his past predictions have been right

Business Insider

time2 hours ago

  • Business Insider

Scott Bessent dismisses Jamie Dimon's debt concerns, saying none of his past predictions have been right

Treasury Secretary Scott Bessent said on Sunday that he doesn't agree with Jamie Dimon's prediction that the bond market will crack. "I've known Jamie a long time and for his entire career he's made predictions like this. Fortunately, none of them have come true. That's why he's a banker, a great banker. He tries to look around the corner," Bessent said in an interview on CBS' "Face the Nation." Dimon, CEO of JPMorgan, told attendees at the Reagan National Economic Forum on Friday that the US "massively overdid" spending and quantitative easing during the COVID-19 pandemic. Dimon predicted this will lead to a "crack in the bond market." "It is going to happen," Dimon said on Friday. "I just don't know if it's going to be a crisis in six months or six years, and I'm hoping that we change both the trajectory of the debt and the ability of market makers to make markets," he added. Bessent said the government is working on shrinking its deficit, and the administration intends to "leave the country in great shape in 2028." "So the deficit this year is going to be lower than the deficit last year, and in two years it will be lower again. We are going to bring the deficit down slowly. We didn't get here in one year, and this has been a long process," Bessent told CBS. Last month, House Republicans passed President Donald Trump's " big beautiful bill." The bill, in its current form, is expected to raise the deficit by $2.5 trillion over the next 10 years, per the Committee for a Responsible Federal Budget. The bill is now with the Senate, and GOP lawmakers hope to have it on Trump's desk by July 4. Dimon isn't the only one who has raised concerns about the US deficit. Last week, Tesla and SpaceX CEO Elon Musk said in an interview with "CBS Sunday Morning" that he was " disappointed to see the massive spending bill." A clip from Musk's interview was released on Tuesday. The full interview aired on Sunday. "I was, like, disappointed to see the massive spending bill, frankly, which increases the budget deficit, not just decrease it, and undermines the work that the DOGE team is doing," Musk said. Musk was the leader of the White House DOGE office from January to May. He announced his departure from the Trump administration on Wednesday. "I think a bill can be big or it could be beautiful. But I don't know if it could be both," Musk told CBS.

COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC
COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC

Epoch Times

time5 hours ago

  • Epoch Times

COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC

Recent data published by the U.S. Centers for Disease Control and Prevention (CDC) shows that a COVID-19 variant that has been circulating since last year is currently the dominant variant in the United States. The LP.8.1 COVID-19 variant, an offshoot of the Omicron strain, was first detected in June 2024, health officials have said. CDC data show that it makes up 73 percent of all cases detected in the country as of May 24, according to an update issued on June 1. The XFC variant is No. 2 at 10 percent, and the XEC variant is third at 4 percent.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store